Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Dmitry Baturin

Concepts (63)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pyrimidines
4
2017
533
0.280
Why?
Pyrazoles
3
2017
510
0.260
Why?
Interleukin-12
1
2019
117
0.140
Why?
Calcineurin
1
2019
105
0.140
Why?
Interferon-alpha
1
2019
197
0.140
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2019
89
0.130
Why?
Recombinational DNA Repair
1
2017
19
0.130
Why?
Phthalazines
1
2017
64
0.120
Why?
Gene Knockdown Techniques
2
2019
336
0.120
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2015
26
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2015
1962
0.110
Why?
Piperazines
1
2017
381
0.110
Why?
Calcineurin Inhibitors
1
2014
69
0.100
Why?
Fusion Proteins, bcr-abl
1
2014
69
0.100
Why?
Hypoxanthine Phosphoribosyltransferase
1
2013
24
0.100
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
127
0.100
Why?
Antimetabolites, Antineoplastic
1
2013
105
0.100
Why?
DNA Repair
1
2015
256
0.100
Why?
Leukemia, Myeloid, Acute
2
2017
684
0.090
Why?
Apoptosis
3
2017
2430
0.090
Why?
Transduction, Genetic
1
2013
133
0.090
Why?
Down Syndrome
1
2019
534
0.090
Why?
Cell Line, Tumor
5
2019
3560
0.080
Why?
Pyrimidinones
3
2017
126
0.080
Why?
Protein-Tyrosine Kinases
1
2013
433
0.080
Why?
Hematopoietic Stem Cells
1
2013
420
0.080
Why?
Drug Synergism
3
2015
357
0.070
Why?
Cell Cycle Proteins
1
2013
630
0.070
Why?
Tumor Suppressor Protein p53
1
2013
533
0.070
Why?
Flow Cytometry
3
2019
1173
0.070
Why?
Nuclear Proteins
1
2013
750
0.070
Why?
Xenograft Model Antitumor Assays
3
2017
931
0.070
Why?
Mice
6
2019
18397
0.050
Why?
Tumor Escape
1
2019
49
0.040
Why?
Animals
6
2019
38180
0.040
Why?
Mice, Inbred C57BL
2
2019
6009
0.030
Why?
Cytarabine
1
2015
66
0.030
Why?
Lymphocyte Activation
1
2019
1127
0.030
Why?
DNA Damage
1
2017
430
0.030
Why?
Dasatinib
1
2014
57
0.030
Why?
Thiazoles
1
2014
136
0.030
Why?
Female
6
2019
78605
0.020
Why?
Thioguanine
1
2013
18
0.020
Why?
Cell Cycle Checkpoints
1
2013
99
0.020
Why?
Cyclosporine
1
2014
265
0.020
Why?
Antigens, CD34
1
2013
88
0.020
Why?
CD8-Positive T-Lymphocytes
1
2019
918
0.020
Why?
Umbilical Cord
1
2013
91
0.020
Why?
CD4-Positive T-Lymphocytes
1
2019
1130
0.020
Why?
Drug Resistance
1
2013
153
0.020
Why?
Myeloid Cells
1
2013
148
0.020
Why?
Disease Progression
1
2019
2855
0.020
Why?
Cytokines
1
2019
2066
0.020
Why?
Humans
7
2019
145307
0.020
Why?
Lymphocytes
1
2013
382
0.020
Why?
Cell Proliferation
1
2017
2506
0.020
Why?
Drug Resistance, Neoplasm
1
2013
886
0.020
Why?
Protein Kinase Inhibitors
1
2014
974
0.020
Why?
Cell Line
1
2013
2882
0.020
Why?
Middle Aged
2
2019
36021
0.010
Why?
Adult
2
2019
40627
0.010
Why?
Male
2
2019
72629
0.010
Why?
Treatment Outcome
1
2014
11731
0.010
Why?
Baturin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)